Our partnership with the Centre for Blood Research (CBR) at the University of British Columbia (UBC) is helping to train the next generation of researchers in transfusion science. This blog post highlights just some of the achievements in education, training or knowledge mobilization accomplished by CBR trainees.  

This is an abbreviated repost that originally appeared on the Centre for Blood Research blog in June 2024. It was written by trainees Joyce Teodoro (PhD student in the lab of Canadian Blood Services’ adjunct scientist Dr. Hongshen Ma) and Kiran Toor (Masters student at CBR in the lab of Dr. Brown), with edits provided by Kaitlyn Chuong (communications and programs coordinator at CBR).  

On April 18th, 2024, the Centre for Blood Research (CBR) held their 12th annual Norman Bethune Symposium, a renowned research event that gathers scientists, clinicians, healthcare professionals, and trainees to discuss advancements in the field of blood research. The symposium was held at UBC Robson Square, on the traditional territory of the Musqueam, Squamish and Tsleil-Waututh people. 

The full day event consisted of expert talks on thalassemia, thrombocytopenia, sickle cell disease, and other bleeding disorders. Research trainees delivered impressive presentations on innovative topics including engineering cells for cancer immunotherapy and computational approaches to inhibit Klebsiella pneumoniae. The event showcased nearly 30 trainee research posters, demonstrating the breadth of ongoing research. 

CBR Director, Dr. Ed Conway, began with the opening remarks, followed by the presentation by Dr. Christian Kastrup, Professor at the Medical College of Wisconsin and Senior Investigator at Versiti Blood Research Institute. Dr. Kastrup’s presentation focused on his work on genetically modifying transfusable donor platelets using mRNA-lipid nanoparticles. Following this, there were a series of presentations on the topic of bleeding disorders. It was a research-filled day that honored the contributions of Drs. Don Brooks and Dana Devine. 

Blood research & reflections 

The symposium was an amazing opportunity to learn about the exciting advances in blood research. It also served as a great platform for speakers to share their personal experiences with blood disorders, as well as for scientists to discuss their professional path in blood sciences. 

Attendees were fortunate to hear Ritika Rakshit share her personal journey with thalassemia, a genetic blood disorder characterized by the body’s inability to produce enough hemoglobin. She detailed her experience from being diagnosed to her treatment plans including being on extramedullary hematopoiesis (EMH) and switching to luspatercept. She offered insights into her hesitancy to switch medications and highlighted the invaluable support of her clinical team. Ritika continues to be an advocate for thalassemia in her role on the patient advocacy board. It was an eye-opening opportunity to be able to hear from a patient reflect on their own journey and understand their perspective on living with a blood disorder. 

Dr. Geraldine Walsh, a development scientist with Canadian Blood Services, also gave an insightful talk describing her career path in blood sciences. Drawing from her experiences, she shared several pieces of advice on navigating a career in science. She highlighted the importance of finding work that we are passionate about, building strong relationships, and learning from those around us. Dr. Walsh concluded her talk by encouraging attendees, especially research trainees, to explore various career opportunities, including those that may deviate from the conventional scientific career trajectory. 

Celebrating Drs. Don Brooks and Dana Devine 

One of the highlights of the symposium was the talk by Dr. Cedric Carter, which celebrated Drs. Don Brooks and Dana Devine’s achievements and contributions. Drs. Don Brooks and Dana Devine are two of the founding members of the Centre for Blood Research (CBR). In addition to their significant and impactful contributions to the field of transfusion science and medicine, they have been instrumental in promoting research and developing initiatives through various leadership roles. Dr. Brooks has served as Associate Vice-President, Research at UBC and Founding Director of UBC’s Support Programs to Advance Research Capacity (SPARC). He has also served as a member of the Board of Directors for TRIUMF, Provincial Health Services Authority, and BC Emergency Health Services. Dr. Devine has held numerous leadership positions, which include her role as chief scientist at Canadian Blood Services, director of the CBR, president of the Association for the Advancement of Blood and Biotherapies (AABB), and editor-in-chief of Vox Sanguinis, a transfusion medicine journal. Their dedication and commitment to scientific discovery through research and development serve as inspiration for future generations of scientists. 

Inaugural Don Brooks and Dana Devine Transfusion Science Innovation Address 

In honour of Drs. Don Brooks and Dana Devine’s scientific contributions to advancing transfusion science and medicine, the inaugural Don Brooks and Dana Devine Transfusion Science Innovation Address was presented by Dr. Stephen Withers. Dr. Withers, in collaboration with Dr. Jay Kizhakkedathu’s lab, worked on identifying efficient enzymes for cleaving terminal sugar structures on the surface of red blood cells (RBCs), which are responsible for determining blood types. By removing these terminal sugar structures, A and B type RBCs can be converted to the universal donor blood type O, which can increase blood supply for transfusion applications. By screening the human gut microbiome for enzymes that can cleave these terminal sugar structures, they identified a pair of enzymes (FpGalNAc deacetylase and FpGalactosaminidase) that can convert type A to type O blood.  

Posters & awards 

This year, there were 29 posters presented by various graduate trainees, postdoctoral fellows, clinical fellows and research associates! These included members within the CBR, but we also had the pleasure of having presenters come from out of town. Multiple trainees from the University of Alberta, University of Toronto & Queen’s University were able to attend the symposium with the support of the CBR Travel Award.  

The Best Poster Presentation went to Dr. Georgina Butler from the Overall Lab for their poster on “SARS-CoV-2 main protease 3CLpro (nsp5), regulates the formation of tunnelling nanotubes by coordinating cytoskeleton reorganization.”  

Our final speaker was Dr. Ed Pryzdial with an exciting talk on Dengue virus-induced thrombocytopenia. Afterwards, a reception was held and attendees got to network and socialize with each other to celebrate the end of another incredible symposium! 

A huge thank you to everyone who attended, to our speakers and all presenters! 

The Centre for Blood Research would like to thank their event sponsors, without whom the 12th Annual Norman Bethune Symposium would not have been possible: the Naiman-Vickars Endowment Fund, Canadian Blood Services, Novo Nordisk, GRIFOLS, CSL Behring, ALEXION, Sobi and Pfizer.  

Canadian Blood Services – Driving world-class innovation 

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.  

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency. 

Dr. Melika Loriamini! 

This new award, in honour of Dr. Dana Devine, supports early career scientists in a field related to transfusion science and medicine, blood banking and blood biotherapies. It is awarded in collaboration with the Canadian Society for Transfusion Medicine’s at their annual conference. 

“I truly appreciate the Committee for the recognition and I'm so proud that I'm the first person to win the Dana Devine Award,” Dr. Loriamini says. “When I walked into the conference, I felt like I was famous because everyone knew who I was. It was a great feeling that all the work, all the hard work, during these years that I did, it's now acknowledged, and everyone knows it.” 

Dr. Loriamini began her career in medical laboratory science in Iran, obtaining a Bachelor of Science degree before immigrating to Canada. She completed a second Bachelor’s degree, this time in biomedical science from York University, and went on to enroll in the laboratory medicine and pathobiology PhD program at the University of Toronto. While completing her education, Dr. Loriamini worked as a Medical Laboratory Technologist at LifeLabs and the William Osler Hospital. 

As part of her PhD, Dr. Loriamini worked with Canadian Blood Services Senior Scientist Dr. Donald Branch which she says allowed her to “acquire expertise in the fields of transfusion medicine and immunology and we were able to publish various articles.” 

In fact, it was Dr. Branch who first sent her the application for the award and told her he thought she was a strong candidate. 

“I want to say thanks to Dr. Branch, who was my supervisor. Actually, thank you is not enough,” Dr. Loriamini says. “He taught me how to think as a scientist and how to become a scientist. I truly appreciate him. He always trusted me.” 

Dr. Loriamini’s research focused on developing a new drug to help people who have autoimmune cytopenias — a cluster of conditions which causes your immune system to attack your own healthy blood cells. She was able to identify a potential drug which is expected to undergo clinical trials in the future.

In addition to receiving the Canadian Blood Services Dana Devine Award, Dr. Loriamini has also been recognized with the Canadian Blood Services Graduate Fellowship Program award in 2019 and 2021, the AABB Outstanding Abstract Award for Trainees as a Fellow/Post-Doctoral Student in 2022, the SGS travel award from the University of Toronto in 2022, the Best Poster for Translation/Basic research award from Hematology Academic Day in 2023, and the Best Poster for Infectious Diseases, Inflammation, and Immunology award from the 2023-Laboratory Medicine & Pathobiology Research Conference. 

Dr. Loriamini is now a Clinical Practice Leader at Humber River Health in Toronto which allows her to bring her research to a clinical setting. Congratulations Dr. Melika Loriamini! 

Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.  

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.